Understanding the natural progression of spondyloarthritis
Official title: Studies on the Natural History and Pathogenesis of Spondyloarthritis
Run by National Institutes of Health Clinical Center (CC) · NCT01422694 · Data updated 2026-11-12
This study looks at how spondyloarthritis develops over time in both kids and adults to see if certain signs can help predict who might get more severe symptoms later on.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 2 Years to 99 Years |
| Sex | All |
| Enrollment | 2000 (estimated) |
| Sponsor | National Institutes of Health Clinical Center (CC) NIH |
| Locations | 1 site (Bethesda, Maryland) |
| Status | Recruiting |
| Started | August 12, 2011 |
| Registry record updated | October 29, 2026 |
| Trial ID | NCT01422694 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include individuals of any age diagnosed with spondyloarthritis and their healthy relatives aged six years and older.
✕Probably not a fit
Patients who do not have spondyloarthritis or its related symptoms will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to investigate the natural history of spondyloarthritis (SpA) in both children and adults. It will involve screening participants with SpA and their healthy relatives to identify symptoms and medical tests that may predict the risk of developing more severe forms of the disease. Participants will undergo physical exams, imaging studies, and biomarker assessments to evaluate the signs and symptoms associated with SpA. The study seeks to establish a cohort for future research on treatment options and disease mechanisms.
Why it matters
Potential benefit: If successful, this study could lead to better identification of patients at risk for severe spondyloarthritis, enabling earlier intervention and improved management.
How similar studies have gone: While there have been studies on spondyloarthritis, this specific approach focusing on the natural history and familial aspects is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
* INCLUSION CRITERIA: To be eligible for follow-up visits, patients must meet the Inclusion Criteria, but not the Exclusion Criteria. Subjects will provide informed consent and then be evaluated either in the outpatient or inpatient unit of the NIH Clinical Center. * Subjects with known or suspected SpA. * Family members of individuals with known or suspected SpA. Family members will not be asked to submit to bone marrow aspiration or interruption of therapy. * Controls for clinical, cellular, molecular, and biochemical assays, and genetic evaluation will be enrolled. Individuals who undergo phlebotomy specifically to provide a control specimen will be 6 years of age or older, and not pregnant. * Minor healthy volunteers undergoing imaging (SI and/or WB MRI) must be old enough to complete the procedure without sedation. Generally this requires that they be at least 6 years of age, so no healthy volunteers under age 6 will be enrolled. * Pregnant people with SpA are allowed to enrolled. Pregnant people will not be asked to undergo an MRI and will not be asked to submit to skin biopsy or bone marrow aspiration. EXCLUSION CRITERIA: * In the case of minors, unavailability of a parent or guardian to provide informed consent. * Presence of any medical condition that would, in the opinion of the investigators, confuse the interpretation of the study. * Unavailability, or inability to comply with the schedule for follow-up visits. * Children under the age of 2 years old. The vast majority of minors with SpA or suspected SpA will be 6 years of age or older. However, it is possible that children younger than age 6 will be evaluated. If children under age 6 are referred for evaluation, we will ensure that they do not have any acute or chronic comorbidity that would preclude them from being safely evaluated at the NIH Clinical Center. Such patients would be referred to other appropriate pediatric hospitals. Based on estimates of the incidence and prevalence of SpA in the pediatric and adult populations we set the accrual ceiling up to 2000. We hope to enroll up to 100 patients per year. Fecal Microbiota Study INCLUSION CRITERIA: 1. Subjects must be enrolled on another NIH natural history protocol, including either 14-AR-0200 (Studies on the Natural History, Pathogenesis and Outcome of Idiopathic Systemic Vasculitis, P. Grayson PI); 18-AR-0081 (Investigation of the Natural History, Genetics, and Pathophysiology of Systemic Juvenile Idiopathic Arthritis, Adult-Onset Still s Disease and Related Inflammatory Conditions, M. Ombrello PI), or 94-E-0165 (Studies in the Natural History and Pathogenesis of Childhood-Onset and Adult-Onset Idiopathic Inflammatory Myopathies, Lisa Rider PI), and meet the respective protocol s criteria for a diagnosis of systemic vasculitis, systemic juvenile idiopathic arthritis, or dermatomyositis. 2. Subjects with definite SpA enrolled on 11-AR-0223 are eligible for the Fecal Microbiota sub-study. 3. Healthy volunteers and pregnant people enrolled on the above protocols are also eligible. EXCLUSION CRITERIA: 1. Inability to provide informed consent or, in the case of minors, unavailability of a parent or guardian. 2. Presence of any medical condition that would, in the opinion of the investigators, expose subjects to more than minimal risk, or confuse the interpretation of the study. 3. Subjects (including healthy volunteers) less than 4 years of age are excluded due to the challenging practical considerations of collecting stool samples, and because spondyloarthritis is much less common in this age group.
Where it's running
-
National Institutes of Health Clinical Center
Bethesda, Maryland, United States Recruiting
Study contacts
- Principal investigator: Sahar Lotfi-Emran, M.D. — National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
- Study coordinator: Sahar Lotfi-Emran, M.D.
- Email: NIAMSSpA@nih.gov
- Phone: (240) 205-2837
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Pain patterns in rheumatic diseases: see if pain works differently in patients and healthy people
This observational study tests how pain is experienced and measured in people with rheumatic diseases compared with healthy volunteers.
-
14-day trial access and brief in-app outcome checks for Axia in axial spondyloarthritis
This project will try whether giving patients immediate 14-day trial access to the Axia app and asking a short five-item questionnaire improves app activation and engagement for people with axial spondyloarthritis.
-
Ultrasound Before Corticosteroid Injection for Arthritis
This trial tests whether applying ultrasound before a corticosteroid joint injection helps improve arthritis symptoms in adults with limb arthritis who need an injection.
-
Ultralow-dose PET scan to detect bone activity with 18F‑NaF
This trial tests whether a new high-sensitivity PET scan using a tiny amount of 18F‑sodium fluoride can produce clear bone images in adults with or without bone disease while cutting radiation exposure by 10–100 times.
-
Early stratification of acute arthritis
The project will collect clinical information and biomarker samples to try to find signs that help classify and guide treatment for adults who developed inflammatory arthritis symptoms within the past 12 weeks.
-
Evaluating neck muscles and balance in men with ankylosing spondylitis
This study is testing how the strength of neck muscles affects balance in men with ankylosing spondylitis compared to healthy men.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.